glp 1 microdosing for perimenopause GLP-1 Agonists in Perimenopause: Unique Risks and Potential Opportunities Is It Safe to Microdose

Warning signs that require immediate medical attention include severe, persistent abdominal pain that radiates to the back, nausea and vomiting that do not improve with usual anti-nausea strategies, and abdominal tenderness that worsens over hours rather than improving

,

Optimal injection route is unestablished

These included: Nausea Reversible darkening of moles An increase in libido or erections The study also noted two much more serious potential side effects associated with Melanotan II

GLP-1 receptor agonists are transforming obesity treatment

doi: 10.1016/j.jhep.2011.10.020 22 EckerJLiebischGEnglmaierMGrandlMRobenekHSchmitzG